Heparanase: A Novel Therapeutic Target for the Treatment of Atherosclerosis

Cardiovascular disease (CVD) is the leading cause of death and disability worldwide, and its management places a huge burden on healthcare systems through hospitalisation and treatment. Atherosclerosis is a chronic inflammatory disease of the arterial wall resulting in the formation of lipid-rich, f...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, Tien K., Paone, Stephanie, Chan, Enoch, Poon, Ivan K. H., Baxter, Amy A., Thomas, Shane R., Hulett, Mark D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599978/
https://www.ncbi.nlm.nih.gov/pubmed/36291066
http://dx.doi.org/10.3390/cells11203198

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599978/
https://www.ncbi.nlm.nih.gov/pubmed/36291066
http://dx.doi.org/10.3390/cells11203198

Ejemplares similares